Popular Articles
Teeth Whitening Products

Race/Ethnicity, Family Income And Education Associated With Sugar Consumption
The intake of added sugars in the United States is excessive, estimated by the US Department of Agriculture in 1999-2002 as 17% of calories a day. Consuming foods with added sugars displaces nutrient-dense foods in the diet. Reducing or limiting intake of added sugars is an important objective in providing overall dietary guidance. In a study of nearly 30,000 Americans published in the August 2009 issue of the Journal of the American Dietetic Association, researchers report that race/ethnicity, family income and educational status are independently associated with intake of added sugars. Groups with low income and education are particularly vulnerable to eating diets with high added sugars.
generic viagra online
New Treatment Method Reduces Pain And Increases Mobility In Patients With Vertebral Compression Fractures
Vesselplasty, a new minimally invasive procedure, increases mobility and reduces pain and the need for pain killers in patients with vertebral compression fractures (VCFs), according to a study performed at the Hospital Universitario Doctor Peset, Valencia, Spain. Vesselplasty is a new alternative to vertebroplasty and kyphoplasty-two conventional VCF treatment methods. Vesselplasty solves the problem of leakage of cement out of the vertebral body which can happen during both vertebroplasty and kyphoplasty," said Lucia Flors, MD, lead author of the study.
News of the day
Tool For Fast Pandemic Detection To Fight Swine Flu
In a joint effort by national laboratory-, university- and private-sector institutions, researchers are developing new tools for rapidly characterizing biological pathogens that could give rise to potentially deadly pandemics such as Influenza A (H1N1).
Nutrition

Wall Street Journal Examines Program To Spur Vaccine Development For Developing World Diseases

The Wall Street Journal examines a $1.5 billion program supported by Italy, the U.K., Canada, Russia, Norway and the Bill & Melinda Gates Foundation that hopes "to encourage pharmaceutical companies to develop vaccines for diseases common to poor countries," which is expected to be announced Friday "on the sidelines of a meeting of top finance officials from the Group of Eight major industrial powers." "Instead of buying existing drugs and giving them away, the donors will guarantee pharmaceutical companies a future market big enough to justify developing and manufacturing new vaccines needed in nations too impoverished to afford them on their own," the newspaper writes. The article explores why insufficient financial incentives tend to keep pharmaceutical companies from developing vaccines targeted to developing countries and how the program aims to overcome these barriers. The first focus of the program is a vaccine for pneumococcal disease, "which kills 1.6 million people in the world a year, the majority of them young children in the developing world," according to the Wall Street Journal, which adds, "The donors chose to go after pneumococcal disease rather than malaria, HIV/AIDS, tuberculosis or other infectious illnesses in part because the prospects appear good that new vaccines could hit the market as early as next year." In collaboration with UNICEF, the World Bank and the GAVI Alliance, the Wall Street Journal writes, the donors "will promise to purchase new pneumococcus vaccines that meet specified criteria for safety, durability and effectiveness." According to the Wall Street Journal, "The U.S. waxed enthusiastic about the approach after Italy and Britain began championing it four years ago, but never came up with a contribution" (Phillips, Wall Street Journal, 6/12). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):